Schedule of Events

    Earn 9.0 SA-CME and 28.75 AMA PRA Category 1 Credits

    Note: schedule is preliminary, and is subject to change.

    This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through joint providership of the Society of Interventional Radiology (SIR) and the Society of Interventional Oncology (SIO).

    SIR is accredited by the ACCME to provide continuing medical education for physicians. SIR designates this live activity for a maximum of 9.0 SA-CME and 28.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Wednesday, 7 June, 2017

    1:00 pm - 6:45 pm Early Career Program, Part I
    1:00 pm - 1:20 pm Introduction Moderator: Sarah White, MD

    1:00 pm - 1:10 pm What is IO and the Future of IO?
    Riad Salem, MD
    1:10 pm - 1:20 pm Why We Are Here?
    Mitchell Berger, JD
    1:20 pm - 2:40 pm The Language of A Tumor Board Moderators: Justin McWilliams, MD and Karen Brown, MD

    1:20 pm - 1:30 pm HCC
    Karen Brown, MD
    1:30 pm - 1:40 pm Liver Mets
    William Rilling, MD
    1:40 pm - 1:50 pm Lung
    Stephen Hunt, MD, PhD
    1:50 pm - 2:00 pm Kidney
    Debra Gervais, MD
    2:00 pm - 2:10 pm Bone
    Matthew Callstrom, MD, PhD
    2:10 pm - 2:40 pm Meet the Professors
    Justin McWilliams, MD; Karen Brown, MD; Debra Gervais, MD; Matthew Callstrom, MD, PhD; Stephen Hunt, MD, PhD; William Rilling, MD
    2:40 pm - 2:50 pm Break
    2:50 pm - 3:45 pm Tumor Board Moderators: Charles Ray, MD, PhD, MS and Michael Soulen, MD
    3:45 pm - 4:45 pm Practice Building Moderators: Riad Salem, and Debra Gervais, MD

    3:45 pm - 4:00 pm How To Build a Clinical IO Practice
    William Rilling, MD
    4:00 pm - 4:15 pm Clinical Care in IO
    Peter Mueller, MD
    4:15 pm - 4:30 pm Importance of Integrating Palliative Care into IO
    Ashraf Thabet, MD
    4:30 pm - 4:45 pm Anesthesia: Types and Benefits
    Michael Brown, MD
    4:45 pm - 5:45 pm Business of IO Moderators: David C. Madoff, MD and Matthew Callstrom, MD, PhD

    4:45 pm - 5:00 pm Documentation of Procedures and E&M
    Matthew Hawkins, MD
    5:00 pm - 5:15 pm Contract Negotiations
    Greg Hill, JD
    5:15 pm - 5:30 pm Managing Complications from a Legal Perspective
    Matt Hanzel, JD
    5:30 pm - 5:45 pm Leadership and Building a Successful Team
    Anne Roberts, MD
    5:45 pm - 6:45 pm Early Career Program Reception
    6:45 pm - 9:15 pm Dinner Symposium: Views of the IO Landscape from a Panel of Three Experts

    6:45 pm - 7:00 pm Who is BTG?
    7:00 pm - 8:00 pm The Latest Clinical Data & Techniques in Radioembolization with TheraSphere©
    Robert Lewandowski, MD
    7:00 pm - 8:00 pm The Latest in Embolization Therapy – Introducing LC Bead Lumi ™
    Edward Kim, MD
    8:15 pm - 8:45 pm Transitioning from Fellowship: Building a Cryoablation Practice
    Hyun Bang, MD
    8:45 pm - 9:15 pm Expert Panel Discussion and Q&A with Attendees

    Thursday, 8 June 2017

    7:00 am Breakfast
    8:00 am - 8:30 am Hands-On Workshops Featuring Demonstrations of Devices and Expert Discussions on Techniques in Radioembolization, Embolization, and Cryoablation
    Presented by BTG (By Invitation Only)
    8:30 am - 9:00 am Welcome - Stephen Solomon, MD
    9:00 am - 9:25 am Reflecting Back and Looking Forward
    ModeratorMatthew Callstrom, MD, PhD 
    Speaker: Riccardo Lencioni, MD 
    9:30 am - 10:30 am Most Influential Publications of 2016-2017 Moderators: Muneeb Ahmed, MD and David C. Madoff, MD

    9:32 am - 9:44 am Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
    Riad Salem, MD
    9:44 am - 9:56 am Tremelimumab in Combination with Ablation in Patients with Advanced HCC
    Tim Greten, MD
    9:56 am - 10:08 am Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study
    Martijn R. Meijerink, MD, PhD
    10:08 am - 10:20 am Irreversible Electroporation versus Radiofrequency Ablation: A Comparison of Local and Systemic Effects in a Small-Animal Model
    Muneeb Ahmed, MD
    10:20 am - 10:30 am Paper 1: Site-Selective Delivery of Novel Trimodal Optical/MR/X-Ray Contrast Bearing Photothermal Nanoconstructs Increases Uptake in Colorectal Liver Metastasis Tumors
    Amit Joshi, PhD
    10:30 am - 11:00 am Break & Exhibits
    11:00 am - 12:00 pm HCC* Moderators: Robert Lewandowski, MD and Yasuaki Arai, MD

    11:00 am - 11:12 am Role of IO in Transplant Surgery
    Parsia Vagefi, MD
    11:12 am - 11:24 am Downstaging to Resection
    Edward Kim, MD
    11:24 am - 11:36 am When SBRT Makes Sense For HCC
    Theodore Hong, MD
    11:36 am - 11:48 am When and How Can IO Match Surgical Outcomes
    Anne Covey, MD
    11:48 am - 12:00 pm IO Techniques Beyond Limitations
    Yasuaki Arai, MD
    12:00 pm - 1:25 pm Lunch Symposia
    12:00 pm - 12:40 pm Changes to the HCC Landscape: Sequential Systemic Therapy to Improve Overall Survival
    Presented By Bayer
    Andrew Zhu, MD
    12:45 pm - 1:25 pm Clinical Treatment of Bone Tumors with the OsteoCool™ RF Ablation System
    Presented By Medtronic
    Moderator: Matthew Callstrom

    Liver Ablation Procedural Advancements with Thermosphere™ Technology
    Presented By Medtronic
    Moderator: Matthew Callstrom
    1:25 pm - 2:00 pm Break & Exhibits
    2:00 pm - 3:30 pm Pulmonary Metastases and Tumor Board Moderators: Robert Suh, MD and Thierry de Baere, MD
    Prostate Moderators: David Woodrum, MD and Lance Mynderse, MD

    Pulmonary Metastases and Tumor Board
    2:00 pm - 2:15 pm Surgical Parenchymal Sparing Approaches to Lung Metastases
    Sidhu Gangadharan, MD
    2:15 pm - 2:30 pm Role of RFA in Parenchymal Sparing Treatment of Lung Metastases
    Thierry de Baere, MD
    2:30 pm - 2:45 pm Outcomes and Complications Using MW for Pulmonary Metastases
    Robert Suh, MD
    2:45 pm - 3:00 pm Advantages of Cryoablation for Treatment of Pulmonary Metastases
    William Moore, MD
    3:00 pm - 3:30 pm Tumor Board
    Moderator: Alice Gillams, MD
    Panelists Thierry de Baere, MD; Sidhu Gangadharan, MD; Robert Suh, MD; William Moore, MD

    2:00 pm - 2:18 pm PIRADS 2: Have We Replaced the Biopsy?
    Candice Bookwalter, MD, PhD
    2:18 pm - 2:36 pm Role of Imaging and Biopsy in Focal Prostate Cancer Treatment Native
    Lance Mynderse, MD
    2:36 pm - 2:54 pm Future of Focal Radiation Therapy Treatment
    Brian Davis, MD
    2:54 pm - 3:12 pm Focal Laser is Not Sufficient, Regional Therapy Needed
    Eric Walser, MD
    3:12 pm - 3:30 pm Focally Recurrent Prostate Cancer Needs Focal Therapy
    David Woodrum, MD
    3:30 pm - 4:00 pm Break & Exhibits
    4:00 pm - 5:00 pm Renal Tumors & Tumor Board Moderators: Debra Gervais, MD and David Breen, MD
    Molecular Biology in IO Moderators: Muneeb Ahmed, MD and Joseph Erinjeri, MD 

    Renal Tumors & Tumor Board
    4:00 pm - 4:10 pm Should Sporadic Sub-3cm Renal Cell Carcinoma Be Treated at All?
    Stu Silverman, MD
    4:10 pm - 4:20 pm Is Renal Tumor Ablation a General Anaesthesia or IV Sedation Procedure?
    Raul Uppot, MD
    4:20 pm - 4:30 pm What Are the Limits of Renal Tumors We Can Treat and How?
    David Breen, MD
    4:30 pm - 4:40 pm Personalized Ablation of Renal Masses: How Does the Interventional Oncologist Pull It All Together in 2017?
    Debra Gervais, MD
    4:40 pm - 5:00 pm Tumor Board
    Moderator: Paul Shyn, MD
    Panelists Stu Silverman, MD; Raul Uppot, MD; David Breen, MD; Debra Gervais, MD

    Molecular Biology in IO
    4:00 pm - 4:15 pm Key Cancer Pathways IO: Science to Practice
    David Woodrum, MD
    4:15 pm - 4:30 pm Transarterial IO: Key Molecular Pathways in Transarterial Therapies
    Stephen Hunt, MD, PhD
    4:30 pm - 4:45 pm Ablation IO: Key Molecular Pathways in IO Therapies
    S. Nahum Goldberg, MD
    4:45 pm - 5:00 pm The Immune System in IO
    Joseph Erinjeri, MD
    5:15 pm - 6:30 pm Debates: IO versus the Pillars of Cancer Care Moderators: S. Nahum Goldberg, MD and J.F. Geschwind, MD

    5:15 pm - 5:40 pm Renal Ablation vs. Partial Nephrectomy
    Debra Gervais, MD vs. Andrew Wagner, MD
    5:40 pm - 6:05 pm Colorectal Cancer: Systemic vs. IO
    Manish Shah, MD vs. William Rilling, MD
    6:05 pm - 6:30 pm Bone: IO vs. RadOnc
    Damian Dupuy, MD vs. Kenneth Olivier, MD
    6:30 pm - 8:00 pm IO Around the World Reception

    Friday, 9 June, 2017

    7:00 am - 7:45 am How I Do It: Experts' Appraoch to Conventional TACE* Edward Kim, MD and Jeff Weinstein, MD
    7:30 am - 8:00 am Breakfast
    7:40 am - 9:00 am Abstract Presentations: Basic Science Moderators:David Woodrum, MD and Andrew Larson, MD
    7:40 am - 7:50 am Paper 3: Establishment and Propagation of Primary Cultured Cell Lines from Hepatocellular Carcinoma Core Needle Biopsy Samples as the Foundation for a Precision Medicine Approach to Hepatocellular Carcinoma Drug Screening
    James Chen
    7:50 am - 8:00 am Paper 4: Development of a Novel Bispecific Antibody for Targeted Immunotherapy of Hepatocellular Carcinoma
    Stephen Hunt, MD, PhD/td>
    8:00 am - 8:10 am Paper 5: Microwave Ablation Induced Changes of the Transcriptome: A Pilot Study
    Paul Laeseke
    8:10 am - 8:20 am Paper 6: Robotically Assisted Sonic Therapy (RAST) for Non-Invasive Liver Ablation in a Porcine Animal Model
    Amanda Smolock
    8:20 am - 8:30 am Paper 7: Assessment of Liver Ablation Using Two-Dimensional Shear-Wave Elastography in Rabbit Liver Model
    Xiaoyan Xie
    8:30 am - 8:40 am Paper 8: Immune Response in Murine HCC After Anti Vascular Ultrasound
    Stephen Hunt, MD, PhD
    8:40 am - 8:50 am Paper 9: Feasibility and Mid-Term Safety of Endobronchial Electroporation with a Novel Catheter Electrode
    Laurien Vroomen, MD
    8:50 am - 9:00 am Paper 10: Multiparametric Longitudinal Quantification of Biological Changes in the Transition Zone of Rat Hepatocellular Carcinoma After Partial Radiofrequency Ablation
    Andrea Cortes
    9:00 am - 9:15 am Break & Exhibits
    9:15 am - 10:15 am Primary Lung Cancer and Tumor Board Moderator: Damian Dupuy, MD and Alice Gillams, MD  
    9:15 am - 9:25 am Can Parenchymal Sparing Surgery Match Outcomes of Lobectomy in Early Stage Lung Cancer?
    Michael Lanuti, MD
    9:25 am - 9:35 am SBRT Can Replace Surgery for Early Stage Lung Cancer
    Stuart Berman, MD
    9:35 am - 9:45 am Microwave Ablation Has Equivalent Outcomes In Parenchymal Sparing Approaches in Early Stage Lung Cancer
    Damian Dupuy, MD
    9:45 am - 9:55 am Will Personalized Medicine Replace the Role of Intervention?
    Sarah Goldberg, MD
    9:55 am - 10:15 am Tumor Board
    Moderator: Bradley Pua, MD
    Panelists: Michael Lanuti, MD; Stuart Berman, MD; Damian Dupuy, MD; Alice Gillams, MD; Sarah Goldberg, MD
    9:15 am - 10:45 am Hands-On Workshop: MSK & Spine Interventions
    Moderator: John Prologo, MD
    Panelists: Afshin Gangi, MD; Joshua Hirsch, MD; Alexis Kelekis, MD
    10:15 am - 10:45 am Break & Exhibits
    10:45 am - 11:45 am Hot Topics in Y90 ǂ 
    Moderators: David C. Madoff, MD & Hooman Yarmohammadi, MD

    MSK & Tumor Board
    Moderators: A. Nick Kurup, MD and Alexis Kelekis, MD

    Hot Topics in Y90
    10:45 am - 10:57 am One Day Y90
    Robert J. Lewandowski, MD
    10:57 am - 11:09 am Retreatment
    Marnix Lam, MD
    11:09 am - 11:21 am When Not to Treat with Y90
    Edward Kim, MD
    11:21 am - 11:33 am Delayed Complications
    David C. Madoff, MD
    11:33 am - 11:45 am Y90 in Heavily Treated Patients
    Hooman Yarmohammadi, MD

    MSK & Tumor Board
    10:45 am - 10:55 am Ablation of Bone Lesions Outside the Spine
    Alexis Kelekis, MD
    10:55 am - 11:05 am Cementoplasty and Other Fixation Techniques for Bone Tumors Outside the Spine
    Sean Tutton, MD
    11:05 am - 11:15 am Ablation and Consolidation as Primary Treatment for Spinal Metastases
    Jack Jennings, MD
    11:15 am - 11:25 am Minimizing Risk in Bone and Soft Tissue Ablation
    A. Nick Kurup, MD
    11:25 am - 11:45 am Tumor Board
    Moderator: Dimitrios Filippiadis MD, PhD
    Panelists: A. Nick Kurup, MD; Alexis Kelekis, MD; Sean Tutton, MD; Jack Jennings, MD
    12:00 pm - 1:25 pm Industry Lunch Symposia 

    12:00 pm - 12:40 pm Get More from Your Embolic. Radiopaque LC Bead Lumi™: See the Difference.
    Presented by BTG

    Edward Kim, MD and Ari Isaacson, MD
    12:45 pm - 1:25 pm Lunch Symposium: Improving Complex Interventional Oncology Outcomes with the Latest Image Guidance Technologies
    Presented by GE

    Technologies and Applications to Support Development of New Embolization Techniques
    David C. Madoff, MD

    Leveraging the Latest Guidance Technologies in Percutaneous Ablation Procedures
    Thierry de Baere, MD
    1:25 pm - 1:45 pm Break & Exhibits
    1:30 pm - 3:00 pm Hands-On Workshop: Guidance and Targeting
    Moderator: Nadine Abi-Jaodeh, MD
    Panelists: Paul Shyn, MD; Robert Liddell, MD; Suvranu Ganguli, MD
    1:45 pm - 2:45 pm Biomarkers in IO Moderators: Constantinos Sofocleous, MD, PhD and Julius Chapiro, MD, PhD

    1:45 pm - 1:55 pm Molecular Pathways and Targets in IO: Past, Present, and Future
    Ryan Corcoran, MD
    1:55 pm - 2:05 pm Radiogenomics: Role in Imaging and Intervention
    Lawrence Schwartz, MD
    2:05 pm - 2:15 pm Biomarkers as Predictors of Outcomes of Tumor Ablation
    Constantinos Sofocleous, MD, PhD
    2:15 pm - 2:25 pm Intraprocedural Imaging Biomarkers to See, Reach, and Treat Liver Cancer
    J.F. Geschwind, MD
    2:25 pm - 2:35 pm Off-Target Effects of Local Tumor Therapies: Consequences for Clinical Practice and Follow-Up Imaging
    Muneeb Ahmed, MD
    2:35 pm - 2:45 pm 3D Quantitative Imaging: Software-Based Solutions and the Future of Machine Learning in IO
    Julius Chapiro, MD, PhD
    2:45 pm - 3:00 pm Break & Exhibits
    3:00 pm - 4:00 pm iMR Moderators:Afshin Gangi, MD and Kamran Ahrar, MD

    3:00 pm - 3:10 pm Interventional MRI Suite: What Do You Need to Establish a Service Line?
    Jan Fritz, MD
    3:10 pm - 3:20 pm When and Where Does MRI Guided Biopsy Add Value
    Sharjeel Sabir, MD
    3:20 pm - 3:30 pm Advantages of MRI Guided Musculoskeletal Interventions
    Kamran Ahrar, MD
    3:30 pm - 3:40 pm Renal Tumors Best Treated with MRI Guidance and Monitoring
    Afshin Gangi, MD
    3:40 pm - 3:50 pm When is MRI Guided Liver Tumor Ablation Preferred?
    Kemal Tuncali, MD
    3:50 pm - 4:00 pm Panel Q&A
    Afshin Gangi, MD; Kamran Ahrar, MD; Jan Fritz, MD; Sharjeel Sabir, MD; Kemal Tuncali, MD
    3:00 pm - 4:30 pm Abstract Presentations: Genitourinary and Pulmonary  Moderators: Ronald Arellano, MD and Sohail Contractor, MD

    3:00 pm - 3:10 pm Paper 11: Percutaneous Microwave Ablation of Renal Cell Carcinoma Using a High Power Microwave System: Focus Upon Feasibility, Safety and Efficacy
    Dimitrios Filippiadis, MD, PhD
    3:10 pm - 3:20 pm Paper 12: Renal Cryoablation: Patterns and Chronology of Late Local Recurrence: Implications for Post-Treatment Surveillance
    Alexander King, MD
    3:20 pm - 3:30 pm Paper 13: Percutaneous Cryoablation of Solitary, Sporadic Clear Cell Renal Cell Carcinoma
    Grant Schmit, MD
    3:30 pm - 3:40 pm Paper 14: Propensity Score-Matched Comparison of Robotic Partial Nephrectomy and Percutaneous Radiofrequency Ablation Regarding the Mid-Term Outcomes for Treating Patients with a T1a Renal Cell Carcinoma
    Byung Kwan Park
    3:40 pm - 3:50 pm Paper 15: Comparison of Complication Rate Between US-Random Prostate Biopsy and US-MRI Fusion Biopsy
    Priscila Falsarella
    3:50 pm - 4:00 pm Paper 16: A Prospective Intra-Patient Blinded Study Comparing 14-Fragments Random Prosatic Biopsy versus mpMRI-TRUS Fusion Biopsy
    Guilherme Mariotti, MD
    4:00 pm - 4:10 pm Paper 17: An Accurate Image-Based Metric for Recurrence Prediction after Lung Cancer Ablation
    Krishna Nand Keshava Murthy
    4:10 pm - 4:20 pm Paper 18: Clinical Outcomes following Microwave Ablation of Sarcoma Pulmonary Metastases: A Single-Centre Experience
    Wen Yu Quak
    4:20 pm - 4:30 pm Paper 19: Comparison of MW to RF Ablation in the Management of Colon Cancer Pulmonary Metastases
    Adrian Gonzalez Aguirre
    4:00 pm - 4:30 pm Break & Exhibits
    4:30 pm - 6:00 pm HCC* Tumor Board 
    : Sarah White, MD & Uei Pua, MD
    Panelists: Yasuaki Arai, MD; Michael Soulen, MD; Karen Brown, MD; Riccardo Lencioni, MD; J.F. Geschwind, MD; Parsia Vagefi, MD; Daniel Pratt, MD; Theodore Hong, MD 
    6:00 pm - 7:00 pm Corporate Advisory Council - By Invitation Only
    6:00 pm - 7:30 pm Early Career Program, Part II
    Research and Innovation in IO Moderators: Alda Tam, MD and Parag Patel, MD

    6:00 pm - 6:12 pm Different Flavors of IO Research
    Alda Tam, MD
    6:12 pm - 6:24 pm Ablation
    Joseph Erinjeri, MD
    6:24 pm - 6:36 pm Device Development
    Fred Lee, MD
    6:36 pm - 6:48 pm Mentor-Mentee Relationship
    Parag Patel, MD
    6:48 pm - 7:00 pm Ongoing Clinical Trials in IO
    Ravi Murthy, MD
    7:00 pm - 7:12 pm Transcatheter Therapies
    Riad Salem, MD
    7:12 pm - 7:24 pm Grants and Funding
    Andrew Larson, PhD
    7:00 pm - 8:00 pm Founding SIO Member Special Event - By Invitation Only 

    Saturday, 10 June, 2017

    7:30 am - 8:00 am Breakfast
    7:30 am - 9:00 am Abstract Presentations: HCC*Moderators: Karen Brown, MD and Julius Chapiro, MD

    7:30 am - 7:40 am Paper 20: Microwave Ablation of Hepatocellular Carcinoma: Outcomes in BCLC 0 and A Patients with Single Versus Multiple Synchronous Tumors
    Katherine Longo, MD
    7:40 am - 7:50 am Paper 21: Measuring Quality of Life after TheraSphere in Hepatocellular Carcinoma (HCC) Patients Using a Digital Patient Engagement Platform
    Riad Salem, MD
    7:50 am - 8:00 am Paper 22: Prognostic Accuracy of Staging Systems for Patients with HCC Undergoing Radioembolization
    Ece Meram, MD
    8:00 am - 8:10 am Paper 23: HCC Screening Behavior and IR Interventions at a Tertiary Transplant Center
    Joe Wildenberg, MD, PhD
    8:10 am - 8:20 am Paper 24: Radiopaque Drug Eluting Beads for Chemoembolization: Early Clinical Experience with Hepatocellular Carcinoma
    Edward Kim, MD
    8:20 am - 8:30 am Paper 25: Long-Term Outcome of Radiofrequency Ablation Versus Hepatic Resection for the Treatment of Hepatocellular Carcinoma 2cm or Smaller
    Harrison Bai, MD
    8:30 am - 8:40 am Paper 26: Long-Term Survival Analysis of 313 Consecutive HCC Patients Treated with Triple Drug TACE or Single Drug TACE with Doxorubicin-Eluting LC Beads
    Antoinette S. Gomes, MD
    8:40 am - 8:50 am Paper 27: Association of Hepatitis C Viral Load with HCC Recurrence After Microwave Ablation
    Ryan O'Hara, MD
    8:50 am - 9:00 am Paper 28: Combined Radiofrequency Ablation and Ethanol Injection Versus Repeat Hepatectomy for Elderly Patients with Recurrent Hepatocellular Carcinoma After Hepatectomy: A Propensity Score Matching Study
    Guangyan Wei, MD
    9:00 am - 9:15 am Break & Exhibits
    9:15 am - 10:15 am Pancreas Moderators: Govindarajan Narayanan, MD and Joshua Weintraub, MD

    9:15 am - 9:27 am Advances in Surgery: What's Considered Resectable
    A. James Moser, MD
    9:27 am - 9:39 am Role of IRE in Surgical Resectability (Open vs. Percutaneous)
    Michael Kluger, MD, MPH
    9:39 am - 9:51 am Role of Sterotactic Body Radiation Therapy in Patients with Locally Advanced and Borderline Resectable Pancreas Cancer
    Chris Crane, MD
    9:51 am -10:03 am Percutaneous Therapy in IRE
    Govindarajan Narayanan, MD
    10:03 am -10:15 am En Bloc Venous and Arterial Resection and Reconstruction for Borderline and Locally Advanced Pancreatic Cancer
    Mark Truty, MD
    9:15 am - 10:45 am Hands-On Workshop: Ablative Therapies
    Moderator: Christos Georgiades, MD
    Panelists: Paul Shyn, MD; Ronald Arellano, MD; A. Nick Kurup, MD
    10:15 am - 10:45 am Break & Exhibits
    10:45 am - 11:45 am Metastatic Colorectal Cancer  Sponsored by an educational grant from Boston Scientific
    Michael Soulen, MD and Ben George, MD

    10:45 am - 11:00 am Parenchymal Sparing Resection is Still Better than Ablation
    Cristina Ferrone, MD
    11:00 am - 11:15 am Thermal Ablation Can Replace Surgery
    Constantinos Sofocleous, MD, PhD
    11:15 am - 11:30 am Should Hepatic Arterial Infusion Be Standard of Care in Metastatic Colorectal Cancer?
    Nancy Kemeny, MD
    11:30 am - 11:45 am When Should IO Therapy Be Integrated into Systemic Therapy?
    Ben George, MD
    12:00 pm - 12:40 pm Lunch Symposium: Cryoablation Benefits, Outcomes, Patient Selection: Lung, Kidney and Liver Applications Presented by BTG
    12:45 pm - 1:25 pm Conventional TACE: Its Key Role in Interventional Radiology* 
    Moderator: David C. Madoff, MD

    12:45 pm - 12:57 pm Role of c-TACE for Down-Staging HCC Patients for Liver Transplant
    Michael Soulen, MD
    12:57 pm - 1:09 pm Evidence for the Combination of c-TACE and Ablation for Liver Mass Treatment
    Sarah White, MD
    1:09 pm - 1:21 pm Imaging Prediction of Outcomes Following c-TACE
    Ryan Hickey, MD
    1:25 pm - 1:45 pm Break & Exhibits
    1:30 pm - 3:00 pm  Hands-On Workshop: Hepatic Intra-Arterial Therapies
    Moderator: Ammar Sarwar, MD
    Panelists: Ron Gaba, MD; Kei Yamada, MD; Katerina Malagari, MD
    1:45 pm - 2:45 pm Advances in IO: Planning, Monitoring, and Assessment Moderators: Matthew Callstrom, MD, PhD and Bradford Wood, MD

    1:45 pm - 2:00 pm Cone Beam CT: Embolization and Ablation
    Nadine Abi-Jaoudeh, MD
    2:00 pm - 2:15 pm Electromagnetic Tracking and Fusion
    Luigi Solbiati, MD
    2:15 pm - 2:30 pm Stereotactic and Robot-Guided Biopsy and Ablation Techniques
    Joachim Kettenbach, MD
    2:30 pm - 2:45 pm Treatment Planning and Monitoring Tools: Software and Thermometry
    Bradford Wood, MD
    2:45 pm - 3:00 pm Break & Exhibits
    3:00 pm - 4:30 pm How I Do It Video Session Moderators: David C. Madoff, MD and Muneeb Ahmed, MD
    Abstract Presentations: HCC & Metastases*
    Moderators: Ravi Murthy, MD and Suvranu Ganguli, MD

    How I Do It Video Session
    3:00 pm - 3:15 pm Irreversible Electroporation of Liver Tumors
    Siddharth Padia, MD
    3:15 pm - 3:30 pm Ablation Therapy with Hybrid PET-CT Guidance
    Paul Shyn, MD
    3:30 pm - 3:45 pm Combined Ablation/Cementoplasty for Bone Metastases
    Julien Garnon, MD
    3:45 pm - 4:00 pm Transsplenic Portal Vein Embolization
    Muneeb Ahmed, MD
    4:00 pm - 4:15 pm Denver Shunts
    Hooman Yarmohammadi, MD
    4:15 pm - 4:30 pm Panel Q&A
    All Faculty

    Abstract Presentations: HCC & Metastases
    3:00 pm - 3:10 pm Paper 29: Adjuvant Medication that Improve Survival After Locoregional Therapy
    Franz Boas, MD
    3:10 pm - 3:20 pm Paper 30: Safety of Yttrium-90 Same Day Lobar Treatment of Bilobar Hepatic Malignancy Compared to Sequential Bilobar Therapy
    Erin Priddy, MD
    3:20 pm - 3:30 pm Paper 31: 3D Imaging Biomarkers for Staging, Prognosis and Treatment Success of Loco-Regional  Therapies of Colorectal Cancer Liver Metastases
    Mansur Ghani
    3:30 pm - 3:40 pm Paper 32: Chronic Hepatotoxicity After Y-90 Radioembolization
    Brian Currie, MD
    3:40 pm - 3:50 pm Paper 33: Comparison of Infection Rates in Patients with Prior Biliary Interventions Undergoing Hepatic Embolotherapy Treated with Single-Drug Moxifloxacin versus Multi-Drug Antibiotic Prophylaxis
    Omar Abousoud
    3:50 pm - 4:00 pm Paper 34: DAXX Mutation is Associated with Poor Response and Shorter Hepatic Progression After Hepatic Artery Embolization of Neuroendocrine Liver Metastases
    Etay Ziv, MD
    4:00 pm - 4:10 pm Paper 35: Chemoembolization Adopting Polyethylene Glycol Drug-Eluting Embolics Loaded with Doxorubicin for the Treatment of Hepatocellular Carcinoma
    Riccardo Carandina, MD
    4:10 pm - 4:20 pm Paper 36: Thermo-Sensitive Liposomal Doxorubicin Plus Radiofrequency Ablation Increased Tumor Destruction and Survival in Medium to Large HCC: A Randomized Double Blinded Dummy-Controlled Clinical Trial in a Single Center
    Wei Yang
    4:20 pm - 4:30 pm Paper 37: Sorafenib With or Without Transarterial Chemoembolization Plus Radiofrequency Ablation for Advanced Recurrent Hepatocellular Carcinoma
    Wei Liang, MD
    4:30 pm - 5:00 pm Break & Exhibits
    5:00 pm - 6:00 pm Metastatic Colorectal Cancer Tumor Board Moderators: Constantinos Sofocleous, MD, PhD and Luigi Solbiati, MD 
    Panelists: Cristina Ferrone, MD; Nancy Kemeny, MD; Ben George, MD; Michael Soulen, MD 
    6:00 pm - 7:30 pm Poster Award Reception: Author Meet & Greet

    Sunday, 11 June, 2017

    7:30 am - 9:00 am Abstract Presentations: Imaging, Guidance, and Technology
    Moderators:Nadine Abi-Jaoudeh, MD and Alexis Kelekis, MD

    7:30 am - 7:40 am Paper 40: Manual Versus Full-Automatic Image Fusion of Real-Time Ultrasound and MR/CT Images for Radiofrequency Ablation of Hepatocellular Carcinoma: An Interim Report of a Randomized Prospective
    Tiral Joon-Il Choi, MD, PhD
    7:40 am - 7:50 am Paper 38: A Novel Technique for Fast Assessment of Tumor Ablation Safety Margin: Pre- and Post-3D-CEUS Mono-Modality Imaging Fusion
    Xiaoyan Xie
    7:50 am - 8:00 am Paper 39: Three-Dimensional Quantitative Color-Coding Analysis on Measurement of the Hepatic Arterial Flow During Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma: A Feasibility Study
    Ethan Lin
    8:00 am - 8:10 am Paper 41: Percutaneous Ablation for Renal Cell Carcinoma Musculoskeletal Metastases: Pain Palliation and Local Tumor Control
    Jack Jennings, MD
    8:10 am - 8:20 am Paper 42: Radiographic Local Tumor Control of Soft Tissue Sarcomas with Percutaneous Ablation
    Jack Jennings, MD
    8:20 am - 8:30 am Paper 43: Portal Vein Thrombus Percutaneous Image Guided Recanalization by Endoluminal RFA and Stenting (VesOpen Procedure): The New Approach in the Management of HCC Patients, Complicated with PVT
    Malkhaz Mizandari, MD
    8:30 am - 8:40 am Paper 44: Quantiative Intra-Procedural Monitoring and Post-Procedural Assessment System for Objective Liver Ablation Margin Assessment and Prediction of Local Recurrence
    Anil Nicholas Kurup, MD
    8:40 am - 8:50 am Paper 45: A Fully Automated Method for Quantitative 3D Tumor Enhancement Analyses Based on Contrast-Enhanced MR Imaging: Application to Liver Cancer Patients Undergoing Transarterial Chemoembolization (TACE)
    Aaron Abajian
    8:50 am - 9:00 am Paper 46: Comparison of Various Embolic Agents, Including ONYX, in Pre-Operative Embolization of Hypervascular Spinal Tumors
    Andrey Tarkhanov
    9:00 am - 9:15 am  Break
    9:15 am - 10:45 am How Did This Happen?! Moderators: Matthew Callstrom, MD, PhD and Michael Soulen, MD

    9:15 am - 9:30 am Cryoablation
    Michael Soulen, MD
    9:30 am - 9:45 am Intra Arterial Therapy
    Katerina Malagari, MD
    9:45 am - 10:00 am Lung Ablation
    Stephen Solomon, MD
    10:00 am - 10:15 am Liver Ablation
    Ron Gaba, MD
    10:15 am - 10:30 am Kidney Ablation
    Thomas Atwell, MD
    10:30 am - 10:45 am Microwave Ablation
    Grant Schmit, MD
    10:45 am - 11:00 am Break
    11:00 am - 12:00 pm Clinical Pearls Moderators: Kevin Kim, MD and Dimitrios Filippiadis, MD, PhD

    11:00 am - 11:10 am Neuroendocrine Liver Metastases
    Sarah White, MD
    11:10 am - 11:20 am HCC*
    Kevin Kim, MD
    11:20 am - 11:30 am Lung
    Stephen Solomon, MD
    11:30 am - 11:40 am Met CRC Liver
    Constantinos Sofocleous, MD, PhD
    11:40 am - 11:50 am Renal
    Raul Uppot, MD
    11:50 am - 12:00 pm Bone
    Dimitrios Filippiadis, MD, PhD

    *Supported by an unrestricited educational grant from Guerbet.
    ǂ Supported by an educational grant from Sirtex